Key Insights

Highlights

Treatment Research

2 treatments under study, led by Nepafenac

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00801905Phase 2TerminatedPrimary

Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal Photocoagulation

Showing all 1 trials

Research Network

Common Treatments

  • Nepafenac1
  • Lubricant1

Active Sponsors

  • Asociación para Evitar la Ceguera en México1

Top Investigators

Related Conditions

  • Macular Edema1

Activity Timeline